Catalyst Event
Bristol-Myers Squibb Co (BMY) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
3/20/2026, 12:00:00 AM
The U.S. FDA and European Commission (EC) granted expanded approvals for Opdivo (nivolumab) for treating classical Hodgkin Lymphoma, announced on March 20, 2026.
Korean Translation
2026년 3월 20일, 미국 FDA 및 유럽위원회(EC)가 전형적 호지킨 림프종 치료를 위한 옵디보(니볼루맙)의 확대 적응증을 승인함.
Related Recent Events
ON Semiconductor Corp (ON) · Other
The company announced it will host its Financial Analyst Day on September 16, 2026, to provide updates on company strategy, growth initiatives, and its long-term financial plan. A low impact is estimated as such events typically provide incremental information. This event is scheduled.
9/16/2026, 12:00:00 AM
Adobe Inc (ADBE) · Earnings Release
Adobe's Q2 2026 earnings release is scheduled for June 12, 2026, which is expected to have a high market impact (>=10%) as it provides the next official update on financial performance scheduled.
6/12/2026, 12:00:00 AM
Dell Technologies Inc (DELL) · Earnings Release
Dell Technologies Fiscal Year 2027 First Quarter results scheduled.
5/28/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA decision on LEQEMBI IQLIK (subcutaneous) for treatment initiation is scheduled. The FDA granted Priority Review for this supplemental Biologics License Application, with a PDUFA action date of May 24, 2026, which is expected. This event is expected to have a high price impact due to the significant market potential of the new delivery method.
5/24/2026, 12:00:00 AM
Vertiv Holdings Co (VRT) · Other
Vertiv will host its 2026 Investor Conference from May 19-20, 2026, where management will provide updates on strategic initiatives and market trends, and this is expected to cause moderate price volatility, scheduled.
5/19/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
The next quarterly earnings release on 2026-05-14 is scheduled.
5/14/2026, 12:00:00 AM